SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Nanotoday who wrote (4824)6/2/2015 12:37:58 PM
From: HardToFind  Read Replies (1) | Respond to of 12871
 
Nanotoday,

I understood the latest 10-Q differently. I read that the company is working on CMC (Chemistry, Manufacturing and Controls) process methodology for producing the drug, which is holding up large-animal tox testing...but I don't recall seeing anything indicating that a new methodology for BASi's tox testing was required.

If the latest filing says BASi's tox testing protocols need to change, I'd like to re-read that section. Can you let me know what page that was on?

Thanks,
HTF